Leukemia Patients Stay In Remission More Than Two Years With New T Cell Therapy

by Blogburger on December 11, 2012

Leukemia patients who received infusions of their own T cells, after the cells had been genetically engineered to fight the patients’ cancerous tumors, reacted to the therapy in a positive way, staying in full remission for over two years…
Featured Health News from Medical News Today

by Amazon Auto Links

Comments on this entry are closed.

Previous post:

Next post: